Niche-based screening identifies small-molecule inhibitors of leukemia stem cellsKimberly A. Hartwell, Todd R. Golub, Joseph Negri et al.|Nature Chemical Biology|2013Cited by 110
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemiaMarcus Järås, Benjamin L. Ebert|The Journal of Experimental Medicine|2014Cited by 93
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cellsMia Eriksson, Marcus Järås|Blood Advances|2017Cited by 47